Novartis' New Breast Cancer Drug | Kisqali® | N18S | CNBC TV18
0:55
Novartis' New Breast Cancer Drug | Kisqali® | N18S | CNBC TV18
8.4K viewsSep 18, 2024
YouTubeCNBC-TV18
KISQALI - Cure for Metastatic Breast Cancer? Top 10 Facts
0:57
KISQALI - Cure for Metastatic Breast Cancer? Top 10 Facts
1.9K viewsSep 16, 2024
YouTubeMedication Quickfacts- Anxiety - Diabetes & MORE
I thought the hard part would be getting through chemo, surgery, and radiation. I thought once the cancer was removed, I'd finally be done. For some of us, that's not how it works. Because my cancer is hormone receptor-positive, was found in my lymph nodes, and there was still residual cancer present after surgery, my team is recommending additional treatments to help lower my risk of recurrence. My next chapter includes: • Zoladex to shut down my ovaries and reduce estrogen production. • Letroz
0:11
I thought the hard part would be getting through chemo, surgery, and radiation. I thought once the cancer was removed, I'd finally be done. For some of us, that's not how it works. Because my cancer is hormone receptor-positive, was found in my lymph nodes, and there was still residual cancer present after surgery, my team is recommending additional treatments to help lower my risk of recurrence. My next chapter includes: • Zoladex to shut down my ovaries and reduce estrogen production. • Letroz
200.4K views4 months ago
TikTokthebreastchapter
🚨 Today, the FDA approved #ribociclib (Kisqali) in combination with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor-positive (HR ), HER2-negative (HER2–) stage II and III early breast cancer at high risk of recurrence. High risk was defined as lymph node positive disease or if lymph node negative, patients either had to have grade 3 or grade 2 AND Ki67>= 20% or high genomic risk (based on assays like Oncotype or mammaprint). Kisqali was given 400 mg daily (*it’
4:47
🚨 Today, the FDA approved #ribociclib (Kisqali) in combination with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor-positive (HR ), HER2-negative (HER2–) stage II and III early breast cancer at high risk of recurrence. High risk was defined as lymph node positive disease or if lymph node negative, patients either had to have grade 3 or grade 2 AND Ki67>= 20% or high genomic risk (based on assays like Oncotype or mammaprint). Kisqali was given 400 mg daily (*it’
22.1K viewsSep 18, 2024
TikTokdrteplinsky
Kisqali for breast cancer treatment is expensive. Ask about the Novartis Patient Support Program!
0:32
Kisqali for breast cancer treatment is expensive. Ask about the Novartis Patient Support Program!
2.2K views7 months ago
YouTubefullyfranchesca
My journey on Kisqali Ribociclib and Letrozole. First time.
2:03
My journey on Kisqali Ribociclib and Letrozole. First time.
733 views6 months ago
YouTubeDonna Finn
Chemo side effects #breastcancer #stage4cancersurvivor #chemosideeffects #kisqali #chemotherapy
2:41
Chemo side effects #breastcancer #stage4cancersurvivor #chemosideeffects #kisqali #chemotherapy
351 views7 months ago
YouTubeStage4 Thriver
3:01
#stage4cancer #metastaticbreastcancer #hope #cancerfighter #kisqali
538 views5 months ago
YouTubeStage4 Thriver
1:05
NATALEE Trial: Eligibility in Early-Stage HR+/HER2 - Breast Cancer
226 views7 months ago
YouTubeOncUpdates: Latest Oncology Insights
1:03
MONALEESA: Ribociclib in First-Line Metastatic Disease
328 views7 months ago
YouTubeOncUpdates: Latest Oncology Insights
0:36
CDK4/6 Inhibitor Drug Interactions — Free Checker at Cyclincare
42 views4 months ago
YouTubeCancer Care Tools
0:31
CDK4/6 Inhibitor Patients — Meet Cyclincare
52 views4 months ago
YouTubeCancer Care Tools
0:05
Efectos secundarios de Kisqali y conversaciones con Benja
1.1M viewsJun 12, 2025
TikTokbenja.abrittaa
1:08
Alanna Vizzoni Cancer Journey: Chemo Pizza Countdown 🍕🎗️
455.2K viewsAug 7, 2024
TikTokalannavizzoni
0:06
It does take work! ngl #breastcancer #zometa #kisqali @nicolaheart444
568.2K viewsSep 29, 2022
TikToknicolaheart444
0:09
Katie Thurston y Eddie Washington: Los Altibajos del Amor
47.7K views11 months ago
TikTokthekatiethurston
2:20
Understanding Kisqali Side Effects in Breast Cancer Treatment
26.2K viewsAug 4, 2025
TikToknicoleeggertofficial
2:59
Kisqali is used in combination with hormone therapy by women who are diagnosed with hormone positive breast cancer. Many women with hormone positive metastatic breast cancer take Kisqali, but recently it has been prescribed to women with early stage breast cancer who have a high risk of cancer reoccurrence. This drug slows down/stops the division of cancer cells. Kisqali is taken orally for 3 years (3 weeks on and 1 week off each month). This drug may cause hair loss, decreased white blood cell
14.3K viewsMar 21, 2025
TikTokkrystalzimbaldi
4:50
Navigating Neutropenia: Treatment Adjustments in Metastatic Cancer
10.8K views7 months ago
TikTokcarlysheag
0:09
🖤 The Sacred Kiswa of the Holy Kaaba 🕋#Kiswa #Kaaba #HolyKaaba #Makkah #MasjidAlHaram #IslamicShor
1.1K views1 month ago
YouTubeMR ZOHAIB ABBAS
See more
Static thumbnail place holder